Morocco Medical Device Regulatory Framework: The Four-Layer Legal Structure

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

Medical device regulation in Morocco is built as a four-layer structure: one law, one implementing decree, four ministerial orders, and the current operational checklists issued by the competent authority. The foundational statute is Loi n° 84-12 relative aux dispositifs médicaux, which contains exactly 51 articles and is the only supreme law in this field. Everything above it — the décret, the arrêtés and the working checklists — exists to operationalize what the law authorizes. Yet in day-to-day practice the layer that actually decides whether a dossier is accepted is the fourth one: the versioned operational checklists maintained by the authority. A submission that is legally sound but formatted against an outdated checklist can still be bounced, while a checklist-compliant dossier travels through intake far more smoothly. GRZAN’s recommendation is therefore a deliberate reversal of the instinct most project teams follow. Do not start from the articles of the law and try to build the dossier downward; start by locking the current checklist version at project kickoff, then trace the requirements back up to the legal provisions that authorize them. Following the sequence the other way around routinely costs more than one full rework cycle, because forms, annexes and formatting expectations are updated far more frequently than the statutes themselves.

2. Legal basis

The instruments below form the backbone of the Moroccan framework for general medical devices. Each entry lists the instrument, its reference number, the publication date, and the specific provisions most relevant to registration projects. Note that the implementing decree and the ministerial orders are the texts that carry the operative deadlines, dossier formats and procedural conditions, while Loi n° 84-12 establishes the obligations themselves.

InstrumentReferencePublication dateProvisions
Medical Devices Law (Loi n° 84-12 relative aux dispositifs médicaux)Dahir n° 1-13-90August 30, 2013; Bulletin officiel n° 6188 of September 19, 201351 articles in total; Articles 12, 14, 15, 18, 19, 23, 50
Implementing decree of Law 84-12 (Décret n° 2-14-607 pris pour l’application de la loi n° 84-12)Décret n° 2-14-607September 18, 2014 (22 kaada 1435)Article 4 (review period); Article 6 (registration certificate validity)
Ministerial order on registration and placing on the market of medical devices (Arrêté du ministre de la santé n° 2855-15)Arrêté n° 2855-15August 4, 2015 (18 chaoual 1436)Dossier tiers; Annex I (conditions and procedures for specific authorizations)
Ministerial orders on establishment declaration and related mattersArrêtés n° 2853-15, 2854-15, 2856-152015Establishment declaration; classification, essential requirements and good practice
Law establishing the Moroccan Agency for Medicines and Health Products (Loi n° 10-22)Dahir n° 1-23-54July 12, 2023Powers of the competent authority

3. Expert insights

Insight 1: The four layers form a chain of delegation, not parallel texts. Loi n° 84-12 makes extensive use of the drafting technique of leaving substantive content to be fixed by way of regulation (fixé par voie réglementaire). The declaration dossier under Article 7, the content of the registration dossier under Article 14, the list of second-hand devices under Article 18, and the traceability lists under Article 23 are all announced in the law itself without a single executable number, format or annex. The law states that these matters exist and matter, but it deliberately does not say how. This means that reading the statute alone is structurally insufficient: a team that stops at the articles simply cannot complete a declaration or a registration file. The chain must be followed all the way down to the current checklists, because the checklists are where the operative detail lives and where version changes happen most often.

Insight 2: Article 50 hands the moment of entry into force to the subsidiary texts. Article 50 provides expressly that the law enters into force on the date of entry into force of the regulatory texts adopted for its implementation, and that those texts must be published in the Bulletin officiel within one year of the law’s publication. During the transition period, the pre-existing registration procedures continue to apply. This clause explains why a law published in 2013 only began operating in practice once the 2014 decree and the 2015 ministerial orders were in place. For planning purposes, the lesson is that no obligation under this framework should be treated as live until its corresponding subsidiary text has been identified and confirmed as published.

Insight 3: Numbering errors circulating in secondary sources must be actively screened out. In the course of verification, GRZAN found that some Chinese-language materials describe the Moroccan medical devices law as “Law No. 84-13, effective 2021”, which does not match the official texts. The correct reference is Loi n° 84-12, promulgated by Dahir n° 1-13-90 on August 30, 2013. Materials that carry the wrong number almost always cite article numbers that also fail to check out against the authentic text, so a single wrong digit is a reliable early warning that an entire secondary source is untrustworthy and must be discarded rather than partially reused.

4. Practical recommendations

  1. Fix the checklist version at the project kickoff meeting. Ask the Moroccan licensed establishment to provide the form numbers, version numbers and applicable dates of the current AMMPS registration checklist and establishment declaration checklist, and record them on the first page of the project master file.
  2. Search from the top down. Verify in the sequence law → decree → ministerial order → checklist. Any element supported only by an unofficial English summary without a citable original reference is to be treated as pending verification.
  3. Maintain a reference-number whitelist. Internal project documents may cite only verified numbers, such as Loi n° 84-12, Décret n° 2-14-607, the Arrêtés n° 2853-15, 2854-15, 2855-15 and 2856-15, and Loi n° 10-22. Any other number must be verified before it is quoted.
  4. Distinguish the statutory layer from the operational layer. The law and the decree define rights and obligations; the checklists define formats and the number of copies. In a dispute about legality, return to the statutes; in a matter of submission mechanics, comply with the checklists.

5. Verification checklist

  • □ The official text of Loi n° 84-12 has been obtained, confirming the reference Dahir n° 1-13-90 and the publication date of August 30, 2013
  • □ The existence of Décret n° 2-14-607 has been confirmed, together with its provisions on the review period and the validity period
  • □ Arrêté n° 2855-15 and the scope of its Annex I have been checked
  • □ The version number and applicable date of the current AMMPS registration checklist have been obtained
  • □ The version number and applicable date of the current AMMPS establishment declaration checklist have been obtained
  • □ No unverified regulatory reference (such as “84-13”) appears anywhere in the project documents
  • □ It has been confirmed that the submissions for this project are addressed to AMMPS and not to the former DMP

Regulatory information verified as of October 30, 2026. GRZAN supports manufacturers and distributors entering the Moroccan market with the full registration lifecycle: framework mapping under Loi n° 84-12 and its subsidiary texts, checklist-version tracking, dossier preparation and review against the current AMMPS forms, coordination with licensed Moroccan establishments, and post-registration maintenance. For project inquiries, contact info@grzanglobal.com.

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail